Upgrade to Finviz Elite: Get our fastest platform speed, real-time data, and unlimited screening & charting. Start Free Trial

Last Close
25.66
Jul 31 • 3:59 PM ET Dollar change-0.04 Percentage change(-0.16%)
Aftermarket Close
25.66
Aftermarket • 7:34 PM ET Dollar change0.00 Percentage change(0.00%)
Jul 30, 3:02 PMBEACON-US real-world evidence for HVHDF therapy drives FMS 3% gain
Index
-
Market Cap
12.59B
Enterprise Value
24.98B
Income
1.09B
Sales
22.44B
Book/sh
28.24
Cash/sh
2.91
Employees
111024
IPO
Sep 17, 1996
P/E
13.50
Forward P/E
10.30
PEG
2.52
P/S
0.56
P/B
0.91
P/C
8.82
P/FCF
6.19
EV/EBITDA
6.29
EV/Sales
1.11
Quick Ratio
0.86
Current Ratio
1.20
Debt/Eq
0.83
LT Debt/Eq
0.65
Option/Short
Yes / Yes
EPS (ttm)
1.90
EPS next Y
2.49
EPS next Q
0.61
EPS this Y
-9.17%
EPS next Y
8.85%
EPS next 5Y
4.08%
EPS past 3/5Y
16.25% -3.43%
Sales past 3/5Y
2.83% 1.71%
EPS Y/Y TTM
67.43%
Sales Y/Y TTM
7.24%
EPS Q/Q
-7.89%
Sales Q/Q
5.03%
Insider Own
0.00%
Insider Trans
-
Inst Own
8.67%
Inst Trans
-2.03%
ROA
3.06%
ROE
7.11%
ROIC
4.34%
Gross Margin
25.96%
Oper. Margin
10.21%
Profit Margin
4.88%
SMA20
5.07%
SMA50
10.33%
SMA200
9.71%
Trades
Shs Outstand
540.18M
Shs Float
490.47M
52W High
27.64 -7.16%
52W Low
20.02 28.17%
Volatility
1.34% 1.31%
ATR (14)
0.44
RSI (14)
71.44
Beta
0.74
Rel Volume
0.67
Avg Volume
768.69K
Volume
513,531
Perf Week
4.35%
Perf Month
12.25%
Perf Quarter
13.69%
Perf Half Y
13.94%
Perf YTD
7.72%
Perf Year
1.26%
Perf 3Y
-1.72%
Perf 5Y
-34.74%
Perf 10Y
-43.79%
Prev Close
25.70
Price
25.66
Change
-0.16%
Date Action Analyst Rating Change Price Target Change
Jul-28-26Downgrade BNP Paribas Exane Neutral → Underperform $19.90
Jul-16-26Initiated Bernstein Mkt Perform
Jan-20-26Downgrade Goldman Buy → Neutral
Oct-15-25Downgrade BofA Securities Neutral → Underperform
Sep-02-25Downgrade UBS Neutral → Sell
Dec-02-24Upgrade BofA Securities Underperform → Neutral
Nov-06-24Initiated Berenberg Buy $25.60
Jan-08-24Downgrade Morgan Stanley Equal-Weight → Underweight
Nov-24-23Upgrade HSBC Securities Reduce → Hold
Nov-17-23Upgrade Societe Generale Hold → Buy
Jul-29-26 09:00AM
Jul-23-26 08:30PM
05:03PM
08:17AM
Jul-20-26 08:00AM
05:20AM Loading…
Jun-25-26 05:20AM
Jun-24-26 06:02PM
Jun-03-26 08:00AM
May-28-26 07:00AM
May-27-26 09:05AM
May-26-26 07:00AM
May-21-26 10:13AM
May-20-26 01:00PM
May-05-26 07:00AM
02:31AM
05:00AM Loading…
Apr-09-26 05:00AM
Apr-02-26 12:58PM
Mar-30-26 05:00AM
Mar-05-26 09:40AM
Feb-25-26 01:55PM
Feb-24-26 08:05PM
04:22PM
03:30PM
02:02PM
09:59AM
07:32AM
07:00AM
03:58AM
Feb-09-26 09:40AM
Feb-05-26 08:33PM
11:40AM Loading…
Jan-26-26 11:40AM
Jan-23-26 09:40AM
Jan-22-26 09:49AM
Jan-16-26 09:27AM
Jan-15-26 09:36AM
Jan-14-26 08:43PM
Jan-12-26 07:45AM
Jan-09-26 11:40AM
07:00AM
Jan-07-26 02:04PM
09:40AM
Dec-18-25 09:50AM
Dec-16-25 09:40AM
Dec-11-25 07:12AM
Dec-10-25 08:00AM
Nov-26-25 09:40AM
Nov-10-25 09:40AM
Nov-05-25 10:53AM
Nov-04-25 04:01PM
09:58AM
07:00AM
Oct-30-25 09:00AM
Oct-27-25 08:43AM
Oct-24-25 01:49PM
Oct-16-25 09:40AM
Oct-07-25 11:40AM
Oct-02-25 09:50AM
Oct-01-25 09:35AM
Sep-24-25 09:40AM
Sep-23-25 01:11PM
Sep-18-25 03:30PM
Sep-10-25 09:00AM
Sep-08-25 04:59PM
Sep-02-25 04:26PM
Aug-19-25 09:40AM
Aug-11-25 12:59PM
07:00AM
Aug-07-25 11:40AM
Aug-06-25 11:01AM
10:39AM
Aug-05-25 10:15AM
07:00AM
01:43AM
01:24AM
Aug-01-25 11:03AM
Jul-31-25 08:30AM
Jul-30-25 09:55AM
Jul-29-25 11:35AM
11:30AM
09:40AM
08:50AM
Jul-24-25 11:33AM
10:50AM
Jul-21-25 11:40AM
Jul-17-25 11:58AM
Jul-16-25 11:02AM
Jul-11-25 09:40AM
Jul-10-25 12:09PM
Jul-09-25 10:36AM
Jul-08-25 03:54AM
Jul-07-25 09:18AM
Jul-04-25 11:40AM
Jul-03-25 08:00AM
Jul-02-25 11:34AM
Jun-30-25 02:29PM
Jun-25-25 09:40AM
Jun-24-25 08:19AM
Jun-18-25 11:40AM
Jun-17-25 11:33AM
08:56AM
Fresenius Medical Care AG engages in the provision of products and services for individuals with renal diseases. It operates through the Care Enablement and Care Delivery segments. The Care Enablement segment is involved in the healthcare products business including research and development, manufacturing, supply chain, and commercial operations as well as supporting functions, such as regulatory and quality management. The Care Delivery segment focuses on the health care services for the treatment of CKD, ESRD, and other extracorporeal therapies, including value and risk-based care programs. The company was founded on August 5, 1996 and is headquartered in Bad Homburg, Germany.
Chair of Management Board & CEOMs. Helen Giza
CFO & Member of the Management BoardMr. Martin Fischer
M.B.A.Mr. Craig Cordola FACHE
Member of the Management BoardDr. Jorg Haring
CEO of Care Enablement & Member of Management BoardMr. Joseph E. Turk Jr.